Stimart Tryn has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 539265 shares of AbCellera Biologics Inc. ($ABCL) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | AbCellera Biologics Inc. | $ABCL | Stimart Tryn | Chief Legal Officer | A | Share option (right to buy) | 539265 | $0.00 | 4,646,012.0000 | 298,875,174 | 13.13% | 0.18% |
| Jan. 1, 2025 | AbCellera Biologics Inc. | $ABCL | Stimart Tryn | Chief Legal Officer | A | Share option (right to buy) | 832033 | $0.00 | 4,106,747.0000 | 294,327,532 | 25.41% | 0.28% |
| Jan. 14, 2024 | AbCellera Biologics Inc. | $ABCL | Stimart Tryn | Chief Legal Officer | A | Share option (right to buy) | 616333 | $0.00 | 3,274,714.0000 | 289,166,486 | 23.18% | 0.21% |